| Symbol | DRTSW |
|---|---|
| Name | ALPHA TAU MEDICAL LTD. |
| Sector | HEALTH CARE |
| Region | Middle East |
| Industry | Medical/Dental Instruments |
| Address | KIRYAT HAMADA ST. 5, JERUSALEM, 9777605, Israel |
| Telephone | +972 3 - 577-4115 |
| Fax | — |
| — | |
| Website | https://www.alphatau.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001871321 |
| Description | Alpha Tau Medical focuses on R&D, and commercialization of Alpha DaRT (Diffusing Alpha-emitters Radiation Therapy) for the treatment of solid cancer tumors. The Alpha DaRT technology was developed in 2003 at Tel Aviv University. Additional info from NASDAQ: |
2026-05-08 13:10
Alpha Tau to Host Conference Call to Discuss Interim Results from First Three Patients Treated for Recurrent Glioblastoma
Read more
2026-05-08 13:00
Alpha Tau Completes Patient Enrollment in its U.S. Pivotal Skin Cancer Study, Advancing Towards Goal of FDA Approval of Alpha DaRT® to Treat Recurrent Cutaneous Squamous Cell Carcinoma
Read more
2026-05-07 13:00
Alpha Tau Successfully Treats First Pancreatic Cancer Patient in Italy with Alpha DaRT® at the University of Verona’s Pancreas Institute
Read more
2026-05-05 13:14
Alpha Tau Announces Upcoming Podium Presentation at the AHNS 12th International Conference on Head and Neck Cancer Showcasing Study Results of Alpha DaRT® Head and Neck Cancer Combination with Pembrolizumab
Read more
2026-05-04 13:17
Alpha Tau Announces 100% Local Disease Control Rate and Favorable Safety Profile Observed in Alpha DaRT® Pancreatic Cancer Trials Presented at DDW 2026
Read more
2026-05-04 07:05
New Form EFFECT - Alpha Tau Medical Ltd. <b>Filed:</b> 2026-05-01 <b>AccNo:</b> 9999999995-26-001447 <b>Size:</b> 1 KB
Read more
2026-04-27 13:01
Alpha Tau Announces Presentation of Pancreatic Cancer Data at Upcoming ASCO Annual Meeting, Showcasing Combined Results from Three Alpha DaRT Pancreatic Cancer Studies
Read more| Trial ID | Title | Phase | Indication | Status | Start Date | Completion Date | Source |
|---|---|---|---|---|---|---|---|
| NCT07290998 | Alpha Radiation Emitters Device (DaRT) for the Treatment of Locally Recurrent P… | Na | Prostate Cancer | Not_Yet_Recruiting | 2026-05-01 | 2029-05-01 | ClinicalTrials.gov |
| NCT06755359 | Alpha Radiation Emitters Device (DaRT) for the Treatment of Locally Advanced Pa… | Na | Pancreatic Cancer | Not_Yet_Recruiting | 2026-01-01 | 2027-06-01 | ClinicalTrials.gov |
| NCT06026943 | Alpha Radiation Emitters Device for the Treatment of Pancreatic Cancer Emitters… | Na | Pancreatic Cancer | Recruiting | 2025-12-04 | 2028-01-01 | ClinicalTrials.gov |
| NCT06615635 | Clinical Study Protocol for Cutaneous SCC for Immunocompromised Patients | Na | Squamous Cell Carcinoma | Not_Yet_Recruiting | 2025-12-01 | 2026-12-01 | ClinicalTrials.gov |
| NCT06910306 | Alpha Radiation Emitters Device (DaRT) for the Treatment of Recurrent Glioblast… | Na | Recurrent Glioblastoma | Recruiting | 2025-10-01 | 2026-12-01 | ClinicalTrials.gov |
| NCT06698458 | Alpha Radiation Emitters Device (DaRT) With Chemotherapy for the Treatment of L… | Na | Pancreatic Cancer | Recruiting | 2025-06-17 | 2026-12-01 | ClinicalTrials.gov |
| NCT05065346 | Neoadjuvant DaRT for Locally Advanced Oral Cavity SCC | Na | Squamous Cell Carcinoma | Not_Yet_Recruiting | 2025-03-01 | 2026-06-01 | ClinicalTrials.gov |
| NCT06202339 | Alpha Radiation Emitters Device for the Treatment of Primary and Recurrent Squa… | Na | Carcinoma of the Vulva | Not_Yet_Recruiting | 2024-04-01 | 2026-12-01 | ClinicalTrials.gov |
| NCT06202248 | A Study to Assess Alpha DaRT224 for the Treatment of Men With Non-metastatic Lo… | Na | Non-metastatic Prostate Cancer | Recruiting | 2024-03-12 | 2027-06-01 | ClinicalTrials.gov |
| NCT06202118 | A Study of Diffusing Alpha Radiation Therapy for Patients With Breast Carcinoma… | Na | Breast Cancer | Recruiting | 2024-02-19 | 2026-06-01 | ClinicalTrials.gov |
| NCT05829291 | Alpha Radiation Emitters Device for the Treatment of Liver Metastases (DaRT) | Na | Liver Metastases | Recruiting | 2023-10-01 | 2026-02-01 | ClinicalTrials.gov |
| NCT05657743 | A Feasibility and Safety Study of Intratumoral Diffusing Alpha Radiation Emitte… | Na | Pancreatic Cancer | Recruiting | 2023-08-16 | 2027-11-01 | ClinicalTrials.gov |
| NCT05632913 | Alpha Radiation Emitters Device for the Treatment of Recurrent Lung Cancer | Na | Recurrent Lung Cancer | Recruiting | 2023-07-01 | 2027-02-01 | ClinicalTrials.gov |
| NCT05781555 | Alpha Radiation Emitters Device (DaRT) for Target Treatments of Malignant Tumors | Na | Malignant Tumor | Recruiting | 2023-03-22 | 2027-04-01 | ClinicalTrials.gov |
| NCT04761146 | A Safety and Efficacy Study of Intra-tumoural Diffusing Alpha Radiation Emitter… | Na | Vulva Cancer, Recurrent | Unknown | 2023-02-28 | 2026-01-01 | ClinicalTrials.gov |
| NCT05323253 | A Clinical Study to Assess the Efficacy and Safety of Alpha DaRT224 for the Tre… | Na | Recurrent Squamous Cell Carcinoma | Recruiting | 2022-09-21 | 2025-12-01 | ClinicalTrials.gov |
| NCT04543903 | Neoadjuvant Interstitial Brachytherapy Using Diffusing Alpha Emitters Radiation… | Na | Prostate Adenocarcinoma | Completed | 2022-05-16 | 2025-10-01 | ClinicalTrials.gov |
| NCT04068155 | Alpha Radiation Emitters Device for the Treatment of of Malignant Cutaneous Tum… | Na | Skin Cancer | Recruiting | 2022-04-01 | 2025-01-01 | ClinicalTrials.gov |
| NCT05125354 | A Retrospective Analysis to Evaluate Long Term Outcomes of SCC Patients Previou… | — | Squamous Cell Carcinoma | Completed | 2022-01-06 | 2022-03-06 | ClinicalTrials.gov |
| NCT05047094 | Alpha Radiation Emitters Device (DaRT) in Combination With Check Point Inhibito… | Na | Head and Neck Squamous Cell Carcinoma | Recruiting | 2021-11-02 | 2027-06-01 | ClinicalTrials.gov |
| NCT03886181 | Alpha Radiation Emitters Device for the Treatment of Cutaneous, Mucosal and Sup… | Na | Skin Cancer | Terminated | 2021-07-08 | 2024-10-13 | ClinicalTrials.gov |
| NCT04534127 | Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous, Mucosal … | Na | Skin Cancer | Recruiting | 2020-12-22 | 2026-01-01 | ClinicalTrials.gov |
| NCT04540588 | Retreatment With Intratumoral Diffusing Alpha Radiation Emitters | Na | Skin Cancer | Completed | 2020-12-22 | 2025-12-01 | ClinicalTrials.gov |
| NCT03889899 | Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous, Mucosal … | Na | Skin Cancer | Recruiting | 2020-10-21 | 2026-09-01 | ClinicalTrials.gov |
| NCT04002479 | Alpha Radiation Emitters Device for the Treatment of Advanced Pancreatic Cancer | Na | Pancreatic Cancer | Active_Not_Recruiting | 2020-10-20 | 2026-10-01 | ClinicalTrials.gov |
| NCT04377360 | Feasibility Trial of Diffusing Alpha-emitter Radiation Therapy (DaRT) for Malig… | Na | Malignant Skin Tumor | Completed | 2020-01-06 | 2022-03-28 | ClinicalTrials.gov |
| NCT03970967 | Alpha Radiation Emitters Device for the Treatment of Newly Diagnosed Breast Car… | Na | Breast Carcinoma | Terminated | 2019-08-28 | 2023-11-30 | ClinicalTrials.gov |
| NCT03737734 | Alpha Radiation Emitters Device for the Treatment of Cutaneous, Mucosal or Supe… | Na | Skin Cancer | Active_Not_Recruiting | 2018-12-31 | 2026-12-01 | ClinicalTrials.gov |
| NCT03353077 | Alpha Radiation Emitters Device for the Treatment of Squamous Cell Carcinoma (D… | Na | Skin Squamous Cell Carcinoma | Completed | 2017-11-21 | 2019-07-14 | ClinicalTrials.gov |
| NCT03015883 | Alpha Radiation Emitters Device for the Treatment of Squamous Cell Carcinoma | Na | Squamous Cell Carcinoma | Completed | 2017-02-22 | 2019-06-25 | ClinicalTrials.gov |
Total clinical trials: 30
| Product Name | Type | Development Stage | Therapeutic Area | Study Status | Trial ID |
|---|---|---|---|---|---|
| Radiation: Diffusing Alpha Radiation Emitters Therapy (DaRT) | Drug | Approved | Pancreatic Cancer | RECRUITING | NCT06698458 |
| Radiation: Diffusing Alpha Radiation Emitters Therapy (DaRT) | Drug | Approved | Pancreatic Cancer | RECRUITING | NCT06698458 |
| Radiation: Diffusing Alpha Radiation Emitters Therapy (DaRT) | Drug | Approved | Pancreatic Cancer | RECRUITING | NCT06698458 |
| Radiation: Diffusing Alpha Radiation Emitters Therapy (DaRT) | Drug | Approved | Pancreatic Cancer | RECRUITING | NCT06698458 |
| Radiation: Diffusing Alpha Radiation Emitters Therapy (DaRT) | Drug | Approved | Pancreatic Cancer | RECRUITING | NCT06698458 |
| Radiation: Diffusing Alpha Radiation Emitters Therapy (DaRT) | Drug | Approved | Pancreatic Cancer | RECRUITING | NCT06698458 |
| Radiation: Diffusing Alpha Radiation Emitters Therapy (DaRT) | Drug | Approved | Pancreatic Cancer | RECRUITING | NCT06698458 |
| Radiation: Diffusing Alpha Radiation Emitters Therapy (DaRT) | Drug | Approved | Pancreatic Cancer | RECRUITING | NCT06698458 |
| Diffusing Alpha Radiation Emitters Therapy (DaRT) | Drug | Approved | Breast Cancer | RECRUITING | NCT06202118 |
| Diffusing Alpha Radiation Emitters Therapy (DaRT) | Drug | Approved | Squamous Cell Carcinoma | COMPLETED | NCT03015883 |
| Radiation: Diffusing Alpha Radiation Emitters Therapy (DaRT) | Drug | Approved | Skin Squamous Cell Carcinoma | COMPLETED | NCT03353077 |
| Diffusing Alpha-emitter Radiation Therapy | Drug | Approved | Malignant Skin Tumor | COMPLETED | NCT04377360 |
| DaRT Diffusing Alpha-emitters Radiation Therapy | Drug | Approved | Vulva Cancer, Recurrent | UNKNOWN | NCT04761146 |
| Device: Radiation: Diffusing Alpha Radiation Emitters Therapy (DaRT) | Drug | Approved | Breast Carcinoma | TERMINATED | NCT03970967 |
| DaRT seeds | Other | Approved | Carcinoma of the Vulva | NOT_YET_RECRUITING | NCT06202339 |
| Diffusing Alpha Radiation Emitters Therapy (DaRT) | Drug | Approved | Liver Metastases | RECRUITING | NCT05829291 |
| Radiation: Diffusing Alpha Radiation Emitters Therapy (DaRT | Drug | Approved | Squamous Cell Carcinoma | NOT_YET_RECRUITING | NCT05065346 |
| DaRT- Diffusing Alpha-emitters Radiation Therapy | Drug | Approved | Skin Cancer | RECRUITING | NCT04068155 |
| Radiation: Diffusing Alpha Radiation Emitters Therapy (DaRT) | Drug | Approved | Skin Cancer | RECRUITING | NCT04534127 |
| Radiation: Diffusing Alpha Radiation Emitters Therapy (DaRT) | Drug | Approved | Pancreatic Cancer | NOT_YET_RECRUITING | NCT06755359 |
| DaRT seeds | Other | Approved | Squamous Cell Carcinoma | NOT_YET_RECRUITING | NCT06615635 |
| Experimental: DaRT seeds | Other | Approved | Non-metastatic Prostate Cancer | RECRUITING | NCT06202248 |
| Radiation: Diffusing Alpha Radiation Emitters Therapy (DaRT) | Drug | Approved | Recurrent Lung Cancer | RECRUITING | NCT05632913 |
| DaRT seeds | Other | Approved | Recurrent Squamous Cell Carcinoma | RECRUITING | NCT05323253 |
| Radiation: Diffusing Alpha Radiation Emitters Therapy (DaRT) | Drug | Approved | Prostate Adenocarcinoma | COMPLETED | NCT04543903 |
| Radiation: Diffusing Alpha Radiation Emitters Therapy (DaRT) | Drug | Approved | Skin Cancer | COMPLETED | NCT04540588 |
| Radiation: Diffusing Alpha Radiation Emitters Therapy (DaRT) | Drug | Approved | Pancreatic Cancer | ACTIVE_NOT_RECRUITING | NCT04002479 |
| Radiation: Diffusing Alpha Radiation Emitters Therapy (DaRT) | Drug | Approved | Skin Cancer | RECRUITING | NCT03889899 |
| DaRT seeds insertion | Other | Approved | Pancreatic Cancer | RECRUITING | NCT06026943 |
| Radiation: Diffusing Alpha Radiation Emitters Therapy (DaRT) | Drug | Approved | Pancreatic Cancer | RECRUITING | NCT05657743 |
| Device: Radiation: Diffusing Alpha Radiation Emitters Therapy (DaRT) | Drug | Approved | Skin Cancer | TERMINATED | NCT03886181 |
| Device :DaRT seeds | Device | Approved | Recurrent Glioblastoma | RECRUITING | NCT06910306 |
| Radiation: Diffusing Alpha Radiation Emitters Therapy (DaRT) | Drug | Approved | Pancreatic Cancer | RECRUITING | NCT06698458 |
| Experimental: DaRT seeds | Other | Approved | Malignant Tumor | RECRUITING | NCT05781555 |
| Pembrolizumab | Other | Approved | Head and Neck Squamous Cell Carcinoma | RECRUITING | NCT05047094 |
| Diffusing Alpha Radiation Emitters Therapy (DaRT) | Drug | Approved | Head and Neck Squamous Cell Carcinoma | RECRUITING | NCT05047094 |
| Radiation: Diffusing Alpha Radiation Emitters Therapy (DaRT) | Drug | Approved | Skin Cancer | ACTIVE_NOT_RECRUITING | NCT03737734 |
| Device :DaRT seeds | DEVICE | Approved | Recurrent Glioblastoma | RECRUITING | NCT06910306 |
| DaRT seeds insertion | DEVICE | Approved | Pancreatic Cancer | RECRUITING | NCT06026943 |
| Experimental: DaRT seeds | DEVICE | Approved | Non-metastatic Prostate Cancer | RECRUITING | NCT06202248 |
| DaRT seeds | DEVICE | Approved | Squamous Cell Carcinoma | NOT_YET_RECRUITING | NCT06615635 |
| Radiation: Diffusing Alpha Radiation Emitters Therapy (DaRT | DEVICE | Approved | Squamous Cell Carcinoma | NOT_YET_RECRUITING | NCT05065346 |
| Pembrolizumab | DRUG | Approved | Head and Neck Squamous Cell Carcinoma | RECRUITING | NCT05047094 |
| DaRT Diffusing Alpha-emitters Radiation Therapy | RADIATION | Approved | Vulva Cancer, Recurrent | RECRUITING | NCT04761146 |
| Diffusing Alpha-emitter Radiation Therapy | RADIATION | Approved | Malignant Skin Tumor | COMPLETED | NCT04377360 |
| DaRT- Diffusing Alpha-emitters Radiation Therapy | DEVICE | Approved | Skin Cancer | RECRUITING | NCT04068155 |
| Device: Radiation: Diffusing Alpha Radiation Emitters Therapy (DaRT) | DEVICE | Approved | Breast Carcinoma | TERMINATED | NCT03970967 |
| Radiation: Diffusing Alpha Radiation Emitters Therapy (DaRT) | DEVICE | Approved | Prostate Cancer | NOT_YET_RECRUITING | NCT07290998 |
| Diffusing Alpha Radiation Emitters Therapy (DaRT) | DEVICE | Approved | Breast Cancer | RECRUITING | NCT06202118 |
Total products: 49